Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB

Molecular Microbiology

Volumn 51, Issue 1, 2004, Pages 123-134

  Aziz, Ramy K ^a   Pabst, Michael J ^a   Jeng, Arthur ^b   Kansal, Rita ^a,c   Low, Donald E ^d   Nizet, Victor ^e   Kotb, Malak ^a,b,c  

^a Univ of TN Health Sciences Center   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; PROTEIN SPEA; PROTEIN SPEB; PROTEOME; STREPTODORNASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; DELETION MUTANT; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE INACTIVATION; GENE SEQUENCE; LYMPHOCYTE ACTIVATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NECROTIZING FASCIITIS; NONHUMAN; PHASE TRANSITION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SHORT SURVEY; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; BACTERIAL PROTEINS; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FASCIITIS, NECROTIZING; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHOCK, SEPTIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STREPTOCOCCUS PYOGENES; TRANSCRIPTION, GENETIC; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; POSIBACTERIA; SPEA; STREPTOCOCCUS GROUP A; STREPTOCOCCUS SP. 'GROUP A';

EID: 0347595329     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2003.03797.x     Document Type: Short Survey

References (36)

1. Ashbaugh, C.D., and Wessels, M.R. (2001) Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun 69: 6683-6688.
2. Banks, D.J., Beres, S.B., and Musser, J.M. (2002) The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol 10: 515-521.
3. Basma, H., Norrby-Teglund, A., Guedez, Y., McGeer, A., Low, D.E., El-Ahmedy, O., et al. (1999) Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 67: 1871-1877.
4. Beres, S.B., Sylva, G.L., Barbian, K.D., Lei, B., Hoff, J.S., Mammarella, N.D., et al. (2002) Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA 99: 10078-10083.
5. Canchaya, C., Proux, C., Fournous, G., Bruttin, A., and Brussow, H. (2003) Prophage genomics. Microbiol Mol Biol Rev 67: 238-276.
6. Chatellier, S., Ihendyane, N., Kansal, R.G., Khambaty, F., Basma, H., Norrby-Teglund, A., et al. (2000) Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun 68: 3523-3534.
7. Collin, M., and Olsen, A. (2001) EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. Embo J 20: 3046-3055.
8. Collin, M., and Olsen, A. (2003) Extracellular ENzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 71: 2983-2992.
9. Cunningham, M.W. (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
10. Davies, H.D., McGeer, A., Schwartz, B., Green, K., Cann, D., Simor, A.E., et al. (1996) Invasive group A Streptococcal infections in Ontario, Canada. N Engl J Med 335: 547-554.
11. Eriksson, A., and Norgren, M. (2003) Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun 71: 211-217.
12. Ferretti, J.J., McShan, W.M., Ajdic, D., Savic, D.J., Savic, G., Lyon, K., et al. (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 98: 4658-4663.
13. Kansal, R.G., McGeer, A., Low, D.E., Norrby-Teglund, A., and Kotb, M. (2000) Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun 68: 6362-6369.
14. Kansal, R.G., Nizet, V., Jeng, A., Chaung, W.-J., and Malak, K. (2003) Selective Modulation of superantigen-induced responses by Streptococcal cysteine protease (SpeB). J Infect D 187: 398-407.
15. Kapur, V., Majesky, M.W., Li, L.-L., Black, R.A., and Musser, J.M. (1993) Cleavage of interleukin 1β (IL-1β) precursor to produce active IL1-β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 90: 7676-7680.
16. Kazmi, S.U., Kansal, R., Aziz, R.K., Hooshdaran, M., Norrby-Teglund, A., Low, D.E., et al. (2001) Reciprocal, temporal expression of speA and speB by invasive M1T1 group A streptococcal isolates in vivo. Infect Immun 69: 4988-4995.
17. Kotb, M. (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8: 411-426.
18. Kotb, M. (1998) Superantigens of gram-positive bacteria: structure-function analyses and their implications for biological activity. Curr Opin Microbiol 1: 56-65.
19. Kotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, M.T., Khurshid, A., et al. (2002) An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 8: 1398-1404.
20. Lei, B., Mackie, S., Lukomski, S., and Musser, J.M. (2000) Identification and immunogenicity of Group A Streptococcus culture supernatant proteins. Infect Immun 68: 6807-6818.
21. Low, D.E., Schwartz, B., and McGeer, A. (1997) The reemergence of severe group A streptococcal disease: An evolutionary perspective. Emerging Pathogens 1: 93-123.
22. Matsumoto, M., Hoe, N.P., Liu, M., Beres, S.B., Sylva, G.L., Brandt, C.M., Haase, G., and Musser, J.M. (2003) Intrahost sequence variation in the streptococcal inhibitor of complement gene in patients with human pharyngitis. J Infect Dis 187: 604-612.
23. Musser, J.M. (1997) Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function. Prep Biochem Biotechnol 27: 143-172.
24. Nizet, V., Beall, B., Bast, D.J., Datta, V., Kilburn, L., Low, D.E., and De Azavedo, J.C. (2000) Genetic locus for streptolysin S production by group A Streptococcus. Infect Immun 68: 4245-4254.
25. Norrby-Teglund, A., and Kotb, M. (2000) Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J Med Microbiol 49: 849-852.
26. Norrby-Teglund, A., Lustig, R., and Kotb, M. (1997) Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates. Infect Immun 65: 5209-5215.
27. Norrby-Teglund, A., Kaul, R., Low, D.E., McGeer, A., Newton, D.W., Andersson, J., Andersson, U., and Kotb, M. (1996) Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 156: 3057-3064.
28. Norrby-Teglund, A., Chatellier, S., Low, D.E., McGeer, A., Green, K., and Kotb, M. (2000) Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 30: 3247-3255.
29. von Pawel-Rammingen, U., and Björck, L. (2003) IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes. Curr Opin Microbiol 6: 50-55.
30. Podbielski, A., Zarges, I., Flosdorff, A., and Weber-Heynemann, J. (1996) Molecular characterization of a major serotype M49 group A streptococcal DNase gene (sdaD). Infect Immun 64: 5349-5356.
31. Proft, T., Moffatt, S.L., Berkahn, C.J., and Fraser, J.D. (1999) Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 189: 89-102.
32. Raeder, R., Woischnik, M., Podbielski, A., and Boyle, M.D. (1998) A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol 149: 539-548.
33. Rasmussen, M., and Björck, L. (2002) Proteolysis and its regulation at the surface of Streptococcus pyogenes. Mol Microbiol 43: 537-544.
34. Schlievert, P.M., Bohach, G.A., Ohlendorf, D.H., Stauffacher, C.V., Leung, D.Y., Murray, D.L., et al. (1995) Molecular structure of staphylococcus and streptococcus superantigens. J Clin Immunol 15 (Suppl. 6): 4S-10S.
35. Stevens, D.L. (1992) Invasive group A Streptococcus infections. Clin Infect Dis 14: 2-13.
36. Thongboonkerd, V., Luengpailin, J., Cao, J., Pierce, W.M., Cai, J., Klein, J.B., and Doyle, R.J. (2002) Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors. J Biol Chem 277: 16599-16605.